Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Machine Learning to Predict Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration.

Ophthalmology science·2026
Same author

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK).

BMJ (Clinical research ed.)·2026
Same author

Code-free automated machine learning for OCT-based classification of vitreoretinal interface diseases.

International journal of retina and vitreous·2026
Same author

Central and Peripheral Alterations of Retinal and Choroidal Vasculature in Multiple Sclerosis: Insights from Multimodal Imaging.

Ophthalmology science·2026
Same author

Residents versus experts in interpreting standard Scheimpflug imaging for the diagnosis of keratoconus.

European journal of ophthalmology·2026

相关实验视频

Updated: Feb 28, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.2K

断层扫描生物标志物因晚期黄斑退行症的进展风险而异.

Enrico Bernardi1, Usha Chakravarthy2, Katherine A Muldrew2

  • 1Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 15, CH-3010, Bern, Switzerland.

Ophthalmology. Retina
|February 26, 2026
PubMed
概括

该研究发现,与年龄相关的黄斑退化 (AMD) 的进展在高风险特征 (HRF) 和亚视网膜德鲁森沉积 (SDD) 之间有所不同. HRF增加了患有新血管AMD (nAMD) 或不患有新血管AMD的地理缩 (FoA) 的风险,而SDD只会进展到FoA,这表明独特的疾病途径.

关键词:
在这个过程中,AMD是AMD.与年龄相关的黄斑变性.更多关于 FOA 的文章人力资源基金 (HRF) 的人力资源基金 (HRF) 是SDD SDD 这是什么意思?焦点缩的焦点缩过度反射的焦点 过度反射的焦点nAMD 的意思是新血管性AMD.下腺类沉积物 下腺类沉积物

更多相关视频

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

相关实验视频

Last Updated: Feb 28, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.2K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

科学领域:

  • 眼科医生 眼科 眼科
  • 遗传学 是一个遗传学.
  • 细胞生物学 细胞生物学

背景情况:

  • 与年龄相关的黄斑退化 (AMD) 是导致视力丧失的主要原因.
  • 截然不同的AMD表型表明疾病机制的潜在差异.
  • 了解进展途径对于向治疗至关重要.

研究的目的:

  • 根据特定特征,调查AMD的不同进展.
  • 为了比较高风险特征 (HRF) 与亚视网膜德鲁森沉积 (SDD) 对AMD进展的影响.
  • 为了阐明驱动AMD结果的独特生物学途径.

主要方法:

  • 纵向AMD患者数据的回顾性分析.
  • 根据已确定的表型对AMD进展进行分类.
  • HRF和SDD组之间的进展率的统计比较.

主要成果:

  • 高风险特征 (HRF) 显著增加了进展为地理缩 (FoA) 的风险,有或没有同时发生的新血管AMD (nAMD).
  • 亚视网膜德鲁森沉积 (SDD) 仅与FOA的进展有关.
  • 观察到的差异表明不同的病理生理机制.

结论:

  • HRF和SDD代表了AMD进展的不同风险因素.
  • 导致FoA的途径根据最初的特征 (HRF与SDD) 不同.
  • 这些发现强调了需要在AMD中制定表型特定的管理策略.